The inflammatory response to cardiopulmonary bypass

International Anesthesiology Clinics

Volumn 34, Issue 2, 1996, Pages 95-108

  Hill, Gary E ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ARGININE; CELL ADHESION MOLECULE; COMPLEMENT; CYTOKINE; DEXAMETHASONE; NITRIC OXIDE;

CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; HEMOFILTRATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INDUCED HYPOTHERMIA; INFLAMMATION; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; REVIEW;

EID: 0029884144     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-199603420-00009     Document Type: Review

References (106)

1. Casey LC. Roles of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993;56:S92-96
2. Llamas R, Forthman HJ. Respiratory distress syndrome in the adult after cardiopulmonary bypass. JAMA 1973;225:1183-1186
3. Jansen NJG, van Oeveren W, Gu YJ, et al. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992;54:744-748
4. Hoffman WD, Natanson C. Endotoxin in septic shock. Anesth Analg 1993;77:613-624
5. Anderson LW, Landow L, Back L, et al. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-α concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993;21:210-217
6. Tao W, Zwischenberger JB, Nguyen TT, et al. Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand. J Thorac Cardiovasc Surg 1995;110:819-828
7. Martinez-Pellus AE, Merino P, Bru M, et al. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 1993;21:1684-1691
8. Schumann RR, Leong SR, Flaggs GW, et al. Structure and function of lipopolysaccharide binding protein. Science 1990;249:1429-1431
9. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) binding protein. Science 1990;249:1431-1433
10. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 1986;163:1433-1450
11. Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells; IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-47
12. Lowry SF. Cytokine mediators of immunity and inflammation. Arch Surg 1993;128:1235-1241
13. Journois D, Pouard P, Greeley WJ, et al. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 1994;81:1181-1189
14. Menasché P, Haydar S, Peynet J, et al. A potential mechanism of vasodilation after warm heart surgery. J Thorac Cardiovasc Surg 1994;107:293-299
15. Haeffner-Cavaillon N, Roussellier N, Ponzio O, et al. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989;98:1100-1106
16. Kawamura T, Wakusawa R, Okada K, et al. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993;40:1016-1021
17. Tulla H, Takala J, Alhava E, et al. Hypermetabolism after coronary artery bypass. J Thorac Cardiovasc Surg 1991;101:598-600
18. Kimmel SC, van de Stouwe MJ, Levin RI, et al. A final common pathway for anti-inflammatory agents: inhibition of leukocyte-endothelial interactions. Trans Assoc Am Physicians 1991;104:113-124
19. Carlos TM, Harlan JM. Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 1990;114:5-28
20. Hughes BJ, Hollers JC, Crockett-Torabi E, et al. Recruitment of GD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 1992;90:1687-1696
21. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434
22. Arnaout MA. Structure and function of the leukocyte adhesion molecules GD11/CD18. Blood 1990;75:1037-1050
23. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990;62:3-6
24. Luscinskas FW, Cybulsky MI, Kiely J, et al. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 1991;146:1617-1625
25. Kukielka GL, Smith CW, Manning AM, et al. Induction of interleukin-6 synthesis in the myocardium. Circulation 1995;92:1866-1875
26. Hill GE, Alonso A, Thiele GM, et al. Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. Anesth Analg 1994;79:23-27
27. Gillinov AM, Bator JM, Zehr KJ, et al. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg 1993;56:847-853
28. Menasché P, Peynet J, Lariviere J, et al. Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions? Circulation 1994;90:II275-II279
29. Leeuwenberg JFM, Smeets EF, Neefjes JJ, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992;77:543-549
30. Dreyer WJ, Michael LH, Nguyen T, et al. Neutrophil-mediated pulmonary injury in a canine model of cardiopulmonary bypass: evidence for a CD18-dependent mechanism. Circulation 1992;86:2502
31. Gillinov AM, Redmond JM, Zehr KJ, et al. Inhibition of neutrophil adhesion during cardiopulmonary bypass. Ann Thorac Surg 1994;57:126-133
32. Wilson I, Gillinov AM, Curtis WE, et al. Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart. Circulation 1993;88:372-379
33. Byrne JG, Smith WJ, Murphy MP, et al. Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg 1992;104:1589-1596
34. Entman ML, Youker KA, Shojit T, et al. Neutrophil induced oxidative injury of cardiac myocytes: a compartmented system requiring CD11b/CD18-ICAM-l adherence. J Clin Invest 1992;90:1335-1345
35. Smith CW, Entman ML, Lance CL, et al. Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-l. J Clin Invest 1991;88:1216-1223
36. Mileski WJ, Winn RK, Vedder NB, et al. Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 1990;108:206-212
37. Vedder NB, Winn RK, Rice CL, et al. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 1988;81:939-944
38. Simon RH, DeHart PD, Todd RF. Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J Clin Invest 1986;78:1375-1386
39. Craddock PR, Fehr J, Brigham KL, et al. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977;296:769-774
40. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012
41. Belvisi MG, Stretton CD, Yacoub M, et al. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharm 1992;210:221-222
42. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci 1991;88:4651-4655
43. Nijkamp FP, Folkerts G. Nitric oxide and bronchial reactivity. Clin Exp Allergy 1994;24:905-914
44. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-1003
45. Kuo H, Liu S, Barnes PJ. The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. Eur J Pharm 1992;221:385-388
46. Berisha H, Pakbaz H, Absood A, et al. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc Natl Acad Sci 1994;91:1-5
47. Folkerts G, Henricks PAJ, Slootweg PJ, et al. Endotoxin-induced inflammation and injury of the guinea pig respiratory airways cause bronchial hyporeactivity. Am Rev Respir Disease 1988;137:1441-1448
48. Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389
49. Doss DN, Estafanous FG, Ferrario CM, et al. Mechanisms of systemic vasodilation during normovolemic hemodilution. Anesth Analg 1995;81:30-34
50. Matheis G, Sherman MP, Buckberg GD, et al. Role of 1-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-H620
51. Depre C, Vanoverschelde J, Goudemant J, et al. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 1995;92:1911-1918
52. Ruvolo G, Greco E, Speziale G, et al. Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg 1994;57:1055-1056
53. 2+-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass. Thorax 1995;50:403-404
54. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993;9:371-377
55. Hill GE, Snider S, Galbraith T, et al. Glucocorticoids reduce bronchial epithelial inflammation during cardiopulmonary bypass. Am J Resp Crit Care Med 1995;152:1791-1795
56. Massaro AF, Gaston B, Kita D, et al. Expired nitric oxide levels during treatment of acute asthma. Am J Resp Crit Care Med 1995;152:800-803
57. Laitinen LA, Heino M, Laitinen A, et al. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606
58. McGowan FX, Ikegami M, del Nido PJ, et al. Cardiopulmonary bypass significantly reduces surfactant activity in children. J Thorac Cardiovasc Surg 1993;106:968-977
59. Macnaughton PD, Braude S, Hunter DN, et al. Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass. Crit Care Med 1992;20:1289-1294
60. Hill G, Ruggeroli A, Pohorecki R, et al. Cigarette smoking reduces endogenous airway nitric oxide production during cardiopulmonary bypass in humans. Anesth Analg 1995;81:170-172
61. Stadler J, Billiar TR, Curran RD, et al. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991;260:C910-C916
62. Schweizer M, Richter C. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Comm 1994;204:169-175
63. Roeise O, Garred P, Mollness TE, et al. Studies on the dose dependence of endotoxin-induced in vitro activation of the complement system. Eur Surg Res 1989;21:34-41
64. Clardy CW. Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B. Infect Immun 1994;62:4549-4555
65. van Deventer SJH, Hack CE, Wolbink CE, et al. Endotoxin-induced neutrophil activation-the role of complement revisited. Prog Clin Biol Res 1991;367:101-109
66. Grisham MB, Everse J, Janssen HE. Endotoxemia and neutrophil activation in vivo. Am J Physiol 1988;254:H1017-H1022
67. Burrell R. Immunomodulation by bacterial endotoxin. Crit Rev Microbiol 1990;17:189-208
68. Witthaut R, Farhood A, Smith CW, et al. Complement and tumor necrosis factor-alpha contribute to Mac-1 (CD11b/CD18) up-regulation and systemic neutrophil activation during endotoxemia in vivo. J Leukoc Biol 1994;55:105-111
69. Okusawa S, Dinarello CA, Yancey KB, et al. C5a induction of human interleukin-1 synergistic effect with endotoxin or interferon-gamma. J Immunol 1987;139:2635-2640
70. Cavarocchi NC, Pluth JR, Schaff HV, et al. Complement activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986;91:252-258
71. Steinberg JB, Kapelanski DP, Oison JD, et al. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-1016
72. Jansen PGM, Velthuis H, Huybregts RA, et al. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits. J Thorac Cardiovasc Surg 1995;110:829-834
73. Niazi Z, Flodin P, Joyce L, et al. Effects of glucocorticoids in patients undergoing coronary artery bypass surgery. Chest 1979;76:262-268
74. Andersen LW, Back L, Thomsen BS, et al. The effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth 1989;3:544-549
75. Ruggeroli AC, Carruthers RG, Pohorecki R, et al. Cardiopulmonary bypassinduced inflammation: steroids vs. aprotinin. Anesthesiology 1995;83:A83
76. Jansen NJG, van Oeveren W, Borek LVD, et al. Inhibition of dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;102:515-525
77. Jansen NJG, van Oeveren W, van Vliet M, et al. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg 1991;5:211-217
78. Barber AE, Coyle SM, Fong Y, et al. Impact of hypercortisolemia on the metabolic and hormonal responses to endotoxin in humans. Surg Forum 1990;41:74-77
79. Rock CS, Coyle SM, Keogh CV, et al. Influence of hypercortisolemia on the acutephase protein response to endotoxin in humans. Surgery 1992;112:467-474
80. Huang ZB, Eden E. Effect of corticosteroids on IL1β and TNFα release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 1993;104:751-755
81. Redl H, Lamche H, Paul E, et al. Effect of methylprednisolone, prednisolone, and dexamethasone on granulocyte function and complement activation. Prog Clin Biol Res 1987;236B:261-272
82. Zitnik RJ, Whiting NL, Elias JA. Glucocorticoid inhibition of interleukin-1 induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanism. Am J Respir Cell Mol Biol 1994;10:643-650
83. Cronstein BN, Kimmel SC, Levin RI, et al. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci 1992;89:9991-9995
84. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-10047
85. Knowles RG, Salter M, Brooks SL, et al. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver, and aorta of the rat. Biochem Biophys Res Comm 1990;172:1042-1048
86. Rees DD, Cellek S, Palmer RMJ, et al. Dexamethasone prevents the induction of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Comm 1990;173:541-547
87. Bone RC, Fisher CJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock, N Engl J Med 1987;317:653-658
88. Bidstrup BP, Royston D, Sapsford RN, et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-372
89. Trapnell JE, Rigby CC, Talbot CH, et al. A controlled trial of Trasylol in the treatment of acute pancreatitis. Brit J Surg 1974;61:177-182
90. Ogata H, Kim S, Fukazawa T, et al. The effects of aprotinin on the phagocytic activity of the reticulo-endothelial system and plasma prekallikrein levels during endotoxin shock. Prog Clin Biol Res 1983;111:309-322
91. Schlag G, Redl H. The proteinases in shock. Resuscitation 1986;14:3-21
92. McMichan JC, Rosengarten DS, Phillipp E. Prophylaxis of post-traumatic pulmonary insufficiency by proteinase inhibitor therapy with aprotinin: a clinical study. Circ Shock 1982;9:107-116
93. Hughes B, Parratt JR. The effects of the protease inhibitor, aprotinin, on the course of shock induced by endotoxin in cats. Brit J Pharmacol 1985;86:399-403
94. Swartholm E, Haglund U, Ljungberg J, et al. Influence of aprotinin, a protease inhibitor, on porcine E. coli shock. Acta Chir Scand 1989;155:7-13
95. Winn R, Gleisner J, Maunder R, et al. Lung permeability and hemodynamics during endotoxemia: effect of aprotinin. J Surg Res 1986;41:620-626
96. Camussi G, Tetta C, Bussolino F, et al. Synthesis and release of platelet-activating factor is inhibited by plasma a 1-proteinase inhibitor or α1-antichymotrypsin and is stimulated by proteinases. J Exp Med 1988;168:1293-1306
97. Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg 1994;58:146-153
98. Hunyadi J, Kenderessy AS, Duda E, etal. Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alpha-mediated cytotoxicity on murine L929 tumor cells. Mol Immunol 1993;30:517-519
99. Whitten CW, Latson TW, Allison PM, et al. Does aprotinin inhibit cardiopulmonary bypass-induced inflammation? Anesthesiology 1992;77:A266
100. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 1993;106:1-9
101. Lord RA, Roath OS, Thompson JF, et al. Effect of aprotinin on neutrophil function after major vascular surgery. Brit J Surg 1992;79:517-521
102. Redmond JM, Gillinov AM, Stuart S, et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 1993;56:474-479
103. Naik SK, Knight A, Elliott M. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991;84:422-431
104. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993;56:1518-1522
105. Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993;56:1499-1502
106. Mink SN, Jha P, Wang R, et al. Effect of continuous arteriovenous hemofiltration combined with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 1995;83:178-190